X0306 4 2022-06-09 0 0001831097 agilon health, inc. AGL 0001855842 Kornitzer Benjamin C/O AGILON HEALTH, INC. 6210 E HWY 290, SUITE 450 AUSTIN TX 78723 0 1 0 0 Chief Med. & Quality Officer Common Stock 2022-06-09 4 M 0 5396 4.49 A 16249 D Common Stock 2022-06-09 4 S 0 5396 20.8982 D 10853 D Common Stock 2022-06-10 4 M 0 5396 4.49 A 16249 D Common Stock 2022-06-10 4 S 0 5396 19.3284 D 10853 D Options (Rights to Buy) 4.49 2022-06-09 4 M 0 5396 0.00 D 2030-01-31 Common Stock 5396 487980 D Options (Rights to Buy) 4.49 2022-06-10 4 M 0 5396 0.00 D 2030-01-31 Common Stock 5396 482584 D Includes restricted stock units. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.79 to $21.015, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.25 to $19.635, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. /s/ Timothy Bensley, as Attorney-in-Fact 2022-06-13